Document Detail


Cognitive, behavioral, and physiological changes in Alzheimer disease patients as a function of incontinence medications.
MedLine Citation:
PMID:  15845759     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Authors evaluated the cognitive, neurophysiologic, and behavioral effects of incontinence medications in patients with Alzheimer disease (AD). METHODS: Nine patients were evaluated, both on and off incontinence medication, for cognitive status, neuropsychiatric status, activities of daily living, and serum anticholinergic level. Caregivers were interviewed to evaluate behavioral status and caregiver burden. RESULTS: Patients showed better performance on specific measures of cognition and behavior when not taking medication for incontinence. A significant, inverse correlation was found between mental status and anticholinergic level. CONCLUSION: Although the sample size was small, the findings suggest that, in patients with AD, incontinence medications with anticholinergic properties may have detrimental effects on mental status and behavior.
Authors:
Rita D Jewart; Joanne Green; Ching-ju Lu; Janet Cellar; Larry E Tune
Related Documents :
21305959 - Medical waivers for atopic conditions did not affect attrition among u.s. military acad...
10955199 - A comparative evaluation of tretinoin gel microsphere, 0.1%, versus tretinoin cream, 0....
18999059 - Performance of online drug information databases as clinical decision support tools in ...
6127129 - Voice analysis of the effects of benzodiazepine tranquillizers.
10110659 - Evaluation and selection of patient-controlled analgesia infusion pumps.
1290569 - Compressive strength of two modern all-ceramic crowns.
19390109 - Medication administration errors in nursing homes using an automated medication dispens...
21838929 - Medication prescribing errors in a pediatric inpatient tertiary care setting in saudi a...
21818229 - Starting a family during medical studies? results of a pilot study on family friendline...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry     Volume:  13     ISSN:  1064-7481     ISO Abbreviation:  Am J Geriatr Psychiatry     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-04-22     Completed Date:  2005-09-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9309609     Medline TA:  Am J Geriatr Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  324-8     Citation Subset:  IM    
Affiliation:
Department of Psychiatry, Emory University School of Medicine, Wesley Woods Health Center, 1841 Clifton Road NE, Atlanta, GA 30329, USA. rjewart@emory.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Activities of Daily Living
Alzheimer Disease / epidemiology*
Benzhydryl Compounds / adverse effects*,  therapeutic use
Caregivers
Cholinergic Antagonists / blood
Cognition Disorders / diagnosis,  epidemiology*
Cresols / adverse effects*,  therapeutic use
Cross-Over Studies
Humans
Memory Disorders / diagnosis,  epidemiology
Mental Disorders / diagnosis,  epidemiology*
Muscarinic Antagonists / adverse effects*,  blood,  therapeutic use
Neuropsychological Tests
Phenylpropanolamine / adverse effects*,  therapeutic use
Psychometrics
Questionnaires
Single-Blind Method
Urinary Incontinence / drug therapy*,  epidemiology*
Wakefulness
Chemical
Reg. No./Substance:
0/Benzhydryl Compounds; 0/Cholinergic Antagonists; 0/Cresols; 0/Muscarinic Antagonists; 124937-51-5/tolterodine; 14838-15-4/Phenylpropanolamine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A pilot study of standardized treatment in geriatric bipolar disorder.
Next Document:  Race and vascular depression risk in community-dwelling older adults.